Not applicableStudy completedNCT03486379What this trial is testingFolfiri as Third Line of TreatmentWho this might be right forGastric CancerRamucirumabThird Line IRCCS Cancer Referral Center of Basilicata 26
Testing effectiveness (Phase 2)UnknownNCT04934618What this trial is testingA Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric CancerWho this might be right forGastric Cancer Nanfang Hospital, Southern Medical University 85
Testing effectiveness (Phase 2)UnknownNCT03959293What this trial is testingClinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastric Cancer Federation Francophone de Cancerologie Digestive 107
Early research (Phase 1)Ended earlyNCT03407976What this trial is testingApatinib With Pembrolizumab in Previously Treated Advanced MalignanciesWho this might be right forAdvanced MalignanciesUrothelial CarcinomaMSI-H or dMMR Solid Tumors+1 more University of Utah 5
Testing effectiveness (Phase 2)UnknownNCT05625737What this trial is testingFruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction AdenocarcinomaWho this might be right forStomach Neoplasms Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Testing effectiveness (Phase 2)UnknownNCT05669807What this trial is testingCamrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerWho this might be right forSecond Line Treatment of Gastric Cancer Zhejiang Cancer Hospital 184
Early research (Phase 1)Looking for participantsNCT06675136What this trial is testingNab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal MetastasesWho this might be right forClinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum City of Hope Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT05643677What this trial is testingFruquintinib Plus Irinotecan in the Treatment of Advanced Gastric CancerWho this might be right forGastric Cancer Fujian Medical University 47
Post-approval studies (Phase 4)Not Yet RecruitingNCT06499610What this trial is testingClinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric CancerWho this might be right forGastric Cancer First Affiliated Hospital Xi'an Jiaotong University 44
Testing effectiveness (Phase 2)UnknownNCT04358341What this trial is testingPegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric CancerWho this might be right forGastric Cancer Sixth Affiliated Hospital, Sun Yat-sen University 136
Not applicableLooking for participantsNCT06417892What this trial is testingFruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ AdenocarcinomaWho this might be right forGastric Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Not applicableLooking for participantsNCT06102759What this trial is testingAdebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody FailedWho this might be right forGastric Cancer Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06977061What this trial is testingEfficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic ProgressionWho this might be right forGastric Neoplasm Queling Liu 30
Testing effectiveness (Phase 2)Looking for participantsNCT06846346What this trial is testingTesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal AdenocarcinomaWho this might be right forMetastatic Esophageal AdenocarcinomaAdvanced Esophageal AdenocarcinomaMetastatic Gastric Adenocarcinoma+1 more UNICANCER 88
Large-scale testing (Phase 3)Active Not RecruitingNCT06346392What this trial is testingAZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2Who this might be right forGastric CancerGastroesophageal Junction Cancer AstraZeneca 594
Not applicableLooking for participantsNCT06102785What this trial is testingFruquintinib Combined With TAS102 for Advanced Gastric CancerWho this might be right forGastric Cancer Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01624025What this trial is testingA Comparative Study of Salvage Treatment With Combination of Docetaxel and EpirubicinWho this might be right forMetastatic Advanced Gastric Cancer Yonsei University 22
Early research (Phase 1)Not Yet RecruitingNCT07594548What this trial is testingFutibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaWho this might be right forClinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+13 more Northwestern University 18
Not applicableUnknownNCT01650766What this trial is testingStudy of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric CancersWho this might be right forGastric Cancer The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 80
Not applicableUnknownNCT06486545What this trial is testingLiposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric CancerWho this might be right forAdvanced Gastric Cancer Hunan Cancer Hospital 18